Introduction: Recently, there have been a number of advances in imaging pancreatic
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …

Pancreatic neuroendocrine tumors (pNETs) are rare and part of the diverse family of
neuroendocrine neoplasms (NENs). Somatostatin receptors (SSTRs), which are widely …

Background and aim The International Cancer of the Pancreas Screening Consortium met in
2018 to update its consensus recommendations for the management of individuals with …

This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the surgical management of pancreatic neuroendocrine tumors …

Introduction: Recent advances in diagnostic modalities and therapeutic agents have raised
the importance of prognostic factors in predicting overall survival, as well as predictive …

Background The optimal surgical strategy for pancreatic neuroendocrine tumors (PNETs) is
unknown. However, current guidelines recommend a watch-and-wait strategy for small …

Methods: Retrospective review of prospectively collected clinicopathologic data of patients
who underwent pancreatectomy between 2000 and 2021 was collected from 4 high-volume …

Pancreatic neuroendocrine tumors (PNETs) are known to be the second most common
epithelial malignancy of the pancreas. PNETs can be listed among the slowest growing as …

This prospective nationwide cohort study examined the feasibility of a watchful-waiting
protocol for non-functional pancreatic neuroendocrine tumours (NF-pNET) of 2 cm or …

Pancreatic neuroendocrine tumors (PanNETs) are a heterogeneous group of neoplasms
with increasing incidence and an ill-defined pathobiology. Although many PanNETs are …